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Gata4, Gata5, and Gata6 represent a subfamily of zinc-finger transcriptional regulators that are important in the development and
differentiation of numerous tissues, including many endodermally-derived organs. We demonstrate that Gata4 and Gata6 have overlapping
expression patterns in the early pancreatic epithelium. Later, Gata4 becomes restricted to exocrine tissue and Gata6 becomes restricted to a subset
of endocrine cells. In addition, we show Gata6, but not Gata4, physically interacts with Nkx2.2, an essential islet transcription factor. To begin
determining the roles that Gata4 and Gata6 play during pancreatic development, we expressed Gata4-Engrailed and Gata6-Engrailed dominant
repressor fusion proteins in the pancreatic epithelium and in the islet. At e17.5, transgenic Gata6-Engrailed embryos exhibit two distinct
phenotypes: a complete absence of pancreas or a reduction in pancreatic tissue. In the embryos that do form pancreas, there is a significant
reduction of all pancreatic cell types, with the few differentiated endocrine cells clustered within, or in close proximity to, enlarged ductal
structures. Conversely, the majority of transgenic Gata4-Engrailed embryos do not have a pancreatic phenotype. This study suggests that Gata6 is
an important regulator of pancreas specification.
© 2006 Elsevier Inc. All rights reserved.Keywords: Gata4; Gata6; Pancreas development; IsletIntroduction
The pancreas regulates glucose homeostasis in two important
ways: the endocrine pancreas produces and secretes hormones,
while the exocrine pancreas produces and secretes digestive
enzymes. The endocrine cells cluster into islets, comprised of α,
β, δ, PP, and ε cells that produce glucagon, insulin, somatostatin,
pancreatic polypeptide, and ghrelin, respectively. In the mouse,
development of the pancreas begins with patterning of the
foregut endoderm around embryonic day (e) 8.5. Cells are
committed to a pancreatic fate by virtue of their unique position
within the endoderm and their proximity to adjacent tissues
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doi:10.1016/j.ydbio.2006.06.046response to signals from surrounding tissues, evagination of the
endoderm leads to formation of the dorsal and ventral pancreatic
buds. From e9.5 to birth, the cells of the pancreatic epithelium
execute a complex program of proliferation, branching, and
differentiation that results in the formation of three primary
structures: the endocrine pancreas, the exocrine pancreas, and
the ductal network (Pictet and Rutter, 1972; Slack, 1995).
Numerous transcription factors have been implicated in the
sophisticated regulatory cascade that occurs during pancreas
development. Before specification of the pancreatic epithelium,
Pdx1 and Ptf1a can be detected in endodermal regions that will
form the dorsal and ventral buds. Pdx1 and Ptf1a null mice do
not develop a mature pancreas, demonstrating that both tran-
scription factors are required for pancreas development (Jonsson
et al., 1994; Krapp et al., 1998; Offield et al., 1996). Early Pdx1
expression is necessary for regionalization of the primitive gut
endoderm and specification of the early pancreatic epithelium,
while a second wave of expression is necessary for maturation of
β cells and insulin regulation (Guz et al., 1995; Wilding and
Gannon, 2004) as well as formation of the exocrine pancreas
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Ptf1a is initially required for specification of all pancreatic cell
types, and has been shown to regulate exocrine differentiation
and enzyme expression during later developmental stages
(Kawaguchi et al., 2002; Rose et al., 2001).
Other transcription factors are also required for differentia-
tion of the endocrine pancreas. The bHLH transcription factor
Ngn3 is transiently expressed in all cells of the endocrine lineage
and is recognized as a marker of endocrine progenitor cells (Gu
et al., 2002). Nkx6.1 is required for proper differentiation of β
cells in the developing pancreas (Sander et al., 2000). Pax6 is
required for normal development of the islet cell types and has
been shown to function as an activator of endocrine hormone
gene transcription (Sander et al., 1997). The homeodomain-
containing transcription factor Nkx2.2 is also required for proper
differentiation of endocrine cell types (Sussel et al., 1998).
Recent studies in our lab have centered on identifying tran-
scription factors that work in concert with Nkx2.2 to regulate
gene expression during pancreas development. Potential
candidates include members of the Gata transcription factor
family because they are known to interact with Nkx2 family
members in other organs. For example, Gata6 and Nkx2.1
interact during lung epithelial development (Bruno et al., 2000;
Liu et al., 2002a; Weidenfeld et al., 2002) and Nkx2.5 interacts
with Gata4 and Gata5 during heart development (Stennard et al.,
2003).
In the mouse, the Gata transcription factor family has six
members and these zinc finger DNA binding proteins recognize
the consensus sequence A/T-GATA-A/G. Gata1, Gata2, and
Gata3 are known to be important for the differentiation of
various cell types in the hematopoietic system while Gata4,
Gata5, and Gata6 have been implicated in the development of
organs derived from endoderm and mesoderm (Molkentin,
2000; Patient and McGhee, 2002). Gata4 is expressed in the
primitive endoderm, heart, liver, small intestine, and gonads of
the embryonic mouse (Arceci et al., 1993). Characterized as an
important activator of many cardiac genes, Gata4 is required for
cardiomyocyte maturation and formation of the heart tube. In
addition, Gata4 is essential for ventral morphogenesis as Gata4
null embryos die between e7.5 and e9.5 due to defects in
development of the visceral endoderm (Kuo et al., 1997;
Molkentin et al., 1997; Narita et al., 1997). Expression of Gata6
during embryonic development is observed in the primitive
streak, allantois, muscle, heart, lung, and gut (Morrisey et al.,
1996). Gata6 plays an important role in lung development,
specifically in branching morphogenesis and later stage dif-
ferentiation of the lung epithelium (Keijzer et al., 2001;
Koutsourakis et al., 2001; Liu et al., 2002b; Yang et al., 2002).
Mice deficient for Gata6 die between e5.5 and e7.5, due to a
defect in the formation of extraembryonic tissues in the
developing blastocyst (Koutsourakis et al., 1999; Morrisey et
al., 1998).
Recently, there have been two conflicting reports on Gata
expression in the pancreas. Ritz-Lazer et al. (Ritz-Laser et al.,
2005) used RT-PCR to demonstrate that Gata4 and Gata6 are
both present in the islet and in endocrine cell lines, and suggest
that Gata4 activates glucagon expression in vitro. However,Ketola et al. (Ketola et al., 2004) reported that Gata6 is expressed
in the endocrine pancreas, while Gata4 expression is restricted to
the exocrine pancreas. Further, they suggest that Gata4 and
Gata6 are not expressed in the early pancreatic epithelium. The
experiments described in our report attempt to resolve this
incongruence and extend the analysis to attempt to determine the
in vivo function of these Gata factors during embryonic pancreas
development.
In this study, we demonstrate that both Gata4 and Gata6 are
expressed at the onset of embryonic mouse pancreas develop-
ment. Further, comprehensive expression analysis confirms that
Gata4 and Gata6 are expressed in mutually exclusive pancreatic
domains at later developmental stages. Since both Gata4 and
Gata6 null mice die prior to formation of the pancreatic buds, we
utilized dominant repressor Gata transgenic mice as an
alternative in vivo approach to investigate the role of Gata
factors in pancreas development. This strategy has been used
successfully to study Gata6 during various stages of embryonic
lung development (Koutsourakis et al., 2001; Liu et al., 2002b;
Yang et al., 2002) and the role of ETS domain transcription
factors in mouse development (Liu et al., 2003). We generated
transient transgenic mice that express the repression domain of
the Drosophila Engrailed protein fused to either full-length
Gata4 or Gata6 or the Gata6 DNA binding domain. Expression
of each fusion protein is driven by the pancreas-specific Pdx1
promoter element (Apelqvist et al., 1997; Li and Edlund, 2001;
Stoffers et al., 1999). From this work, we conclude that Gata6
plays an important role in pancreas specification as well as the
development of endocrine cell types.
Materials and methods
Construction of the Gata transgenes and generation of transgenic
embryos
Three Gata transgenic constructs were created as follows: The repression
domain of the Drosophila Engrailed (EnR) gene (encoding amino acids 1–298)
was PCR-amplified from the pCS2:EnR plasmid (K. Artinger, UCHSC).
Primers included 5′ BamHI and 3′ XhoI sites for cloning. A FLAG tag was
added, in frame, by cloning the EnR sequence into the BamHI and XhoI sites of
the pCMV-Tag4B vector (Stratagene) to produce pCMV-Tag4B-EnR. Full-
length Gata6 cDNA, full-length Gata4 cDNA, and the Gata6 DNA binding
domain (encoding amino acids 232–354) were PCR-amplified from cDNA and
cloned into the pCR®-Blunt II-TOPO® vector (Invitrogen). The Gata cDNA
inserts were released by digestion and cloned into the BamHI site of pCMV-
Tag4B-EnR to produce pCMV-Tag4B-G6FLEnR, pCMV-Tag4B-G4FLEnR,
and pCMV-Tag4B-G6DBDEnR. Finally, the fusion constructs were PCR-
amplified from their respective pCMV-Tag4B vectors and blunt-end cloned into
the EcoRI site of the pPDX1-EcoRI vector (J. Jensen, UCHSC) to produce
Pdx1:G6FLEnR, Pdx1:G4FLEnR, and Pdx1:G6DBDEnR. A control transgenic
construct was created as follows: The repression domain of the Drosophila
Engrailed gene (EnR) was PCR-amplified from the pCS2:EnR plasmid using
primers that added a 5′ EcoRI site and nuclear localization sequence (encoding
PKKKRKV) as well as a 3′ XhoI site. The PCR product was cloned into the
pCR®-Blunt II-TOPO® vector to produce TOPO:NLSEnR. A FLAG tag was
added, in frame, by cloning the NLSEnR sequence into the EcoRI and XhoI
sites of pCMV-Tag4B to produce pCMV-Tag4b-NLSEnR. The NLSEnR
construct was PCR-amplified from pCMV-Tag4b-NLSEnR and blunt-end
cloned into the EcoRI site of the pPDX1-EcoRI vector to produce Pdx1:
NLSEnR. Pdx1:G6FLEnR, Pdx1:G6DBDEnR, and Pdx1:NLSEnR were
linearized with DraIII, while Pdx1:G4FLEnR was linearized with Sap1. The
transgenic constructs were subsequently purified using the QIAquick Gel
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oocytes, which were subsequently transferred into pseudopregnant females
(UCCC Transgenic/Knockout Core Facility).
Embryo fixation and tissue preparation
15.5 to 17.5 days following injection of the transgenic construct, embryos
were harvested and fixed overnight in 4% paraformaldehyde. Following
cryoprotection in 30% sucrose overnight at 4°C, the tissue was embedded and
frozen in OCT. Embryos were sectioned at 8–10 μm.
PCR genotyping
DNA was extracted from tail tissue removed from the embryos upon
dissection. Primers and conditions used for genotyping transgenic mice are
documented in Table 1.
Immunohistochemistry and in situ hybridization
All immunohistochemistry was performed on frozen sections as previously
described (Norgaard et al., 2003). Primary antibodies were used as indicated:
guinea pig α-insulin 1:1000 (Linco), rabbit α-glucagon 1:1000 (Phoenix
Pharmaceuticals), rabbit α-amylase 1:1000 (Sigma), rabbit α-somatostatin
1:200 (Phoenix Pharmaceuticals), rabbit α-ghrelin 1:1000 (Phoenix Pharma-
ceuticals), Fluorescein-Dolichos biflorusAgglutinin 1:100 (DBA-Lectin, Vector
Laboratories), rabbit α-Pdx1 1:1000 (Chemicon), rabbit α-Pax6 1:300
(Chemicon), rabbit α-Nkx6.1 1:800 (Novo Nordisk A/S), goat α-Gata4 1:100
(Santa Cruz Biotechnology), mouse α-Vimentin 1:25 (DakoCytomation).
Secondary antibodies were used as indicated: Alexa Fluor 488 and 594 1:400
(Molecular Probes), and HRP-conjugated antibodies according to manufac-
turer's instructions (Vectastain ABC Kit).
RNA in situ hybridization was performed as previously described (Prado et
al., 2004) using antisense riboprobes transcribed from linearized plasmids.
Riboprobes were generated for Gata4, Gata6, Ngn3, and Nkx2.2 from full-
length cDNA. A riboprobe targeting mRNA encoding the Drosophila EnR
repression domain was generated from the pCS2:EnR plasmid.
Microscopy and imaging
Images were obtained with a Leica DM5000 microscope and an Evolution
MP Color camera, and were processed using ImagePro software from Media
Cybernetics.
Cell culture
AR42J cells were cultured and maintained according to protocols from
American Type Culture Collection (Manassas, VA).
Protein–protein interactions
The yeast two-hybrid assay was performed using the Clontech Matchmaker
Two-hybrid system. The Nkx2.2 bait clone was introduced into the pAS2-1Table 1
PCR primers and conditions
Transgene Primers
Pdx1:G6FLEnR (KD71) 5′-GTGCCTCGACCACTTGCTATGAA
(KD73) 5′-TGGTGTGCGTCTGATTGTGGAAA
Pdx1:G6DBDEnR (KD76) 5′-AAATGCAGCATCTTCACCACCAG
(KD79) 5′-TAGGCAGCCGGATTGAAGCAGTT
Pdx1:G4FLEnR (KD25) 5′-GGCGTGGAAATATTCTTATTGG-3
(KD31) 5′-TCAAACATATCGAGATTGGGG-3′
Pdx1:NLSEnR (TM9) 5′-TCCTGCCTTTCTCTTTATGGTTACA
(KD22) 5′-GCTAAACTCCAGCAGATCCAC-3′(GAL4 DNA binding domain) vector and the Gata prey plasmids were cloned
into the pACT2 (GAL4 activation domain) vector. All assays were performed in
the yeast Y190 strain according to manufacturer's directions. To generate an
Nkx2.2 two-hybrid bait construct without autonomous activation activity, we
identified and deleted two distinct activation domains of the Nkx2.2 gene: amino
acids 20–97 and amino acids 244–273 (Grasch and Sussel, unpublished data).
Specifically, full-length Nkx2.2 cDNAwas cloned into pBluescript and an NcoI
site was introduced at the Nkx2.2 start codon by PCR-mediated site-directed
mutagenesis. A XhoI site was then introduced by PCR-mediated site-directed
mutagenesis at base pair 400 and the resulting plasmid was digested with XhoI
and religated to delete the sequence between the engineered XhoI site and the
endogenous XhoI site at base pair 637 (amino acids 20–97 of the Nkx2.2
protein). The resulting Nkx2.2–NcoIΔ20–97 vector was digested with NcoI and
PstI to truncate the Nkx2.2 protein at amino acid 244 and delete the 3′ activation
domain. (A Pst1 site is located at base pair 1067 in the Nkx2.2 cDNA.) The
resulting fragment was cloned into the NcoI and PstI sites of the pAS2-1 vector
(Clontech). Full-length Gata4 and Gata6 coding sequences were cloned in frame
into the pACT2 vector (Clontech). pACT:Gata6-N-terminus was created by
digesting the pACT:Gata6 full-length with SacI and religating to delete C-
terminal Gata6 sequences between the endogenous SacI site and the pACT
polylinker site, thereby removing the C-terminal portion of Gata6 containing the
zinc fingers. Colony lift filter β-galactosidase assays were performed as
recommended by the manufacturer (Clontech).
In vitro pull-down assays were performed using bacterially-generated
Maltose-binding protein (MBP)-Nkx2.2 fusion protein and 35S-labeled in vitro
translated Gata6. Full-length Nkx2.2 was cloned in frame into the pMAL-c2X
vector (New England Biolabs) and transformed into the BL21 E. coli strain
(Stratagene). Extracts containing the MBP-Nkx2.2 fusion protein were prepared
as described (Sepulveda et al., 1998), and MBP-fusion proteins were immo-
bilized on amylose beads according to the manufacturer's instructions. Full-
length Gata6 was cloned into a pBluescript vector downstream from the T7
promoter. Binding assays were performed with labeled Gata6 protein synthe-
sized in vitro using the TNT® Coupled Reticulocyte Lysate System (Promega)
in the presence of 35S-labeled cysteine and 35S-labeled methionine (Amersham)
according to the manufacturer's instructions. Immobilized MBP-Nkx2.2 fusion
protein andMBP control protein were incubated with 35S-labeled proteins for 1–
2 h at 4°C while rotating in protein binding buffer containing 20 mM HEPES
(pH 7.9), 150 mM KCl, 25 mMMgCl2, 1 mM DTT, 10% glycerol, 0.1% Triton
X-100, 0.1% NP-40 (IGEPAL CA-630, Sigma). Beads were washed three times
in protein binding buffer. Bound proteins were eluted from the beads into SDS-
sample buffer by boiling and resolved by SDS-PAGE. Gels were dried onto
Whatman paper and analyzed for autoradiography using a Storm phosphoima-
ger (Molecular Devices).
For co-immunoprecipitation assays, COS-7 cells were transfected with
pcDNA3:Gata6 and pcDNA3:Myc-Nkx2.2 using FuGene 6 (Roche) following
the manufacturer's instructions. Cells were harvested 2–3 days post-
transfection by incubating in PBS lysis buffer containing either 1 mM
EDTA, 1 mM DTT, 0.1% Triton X-100 and protease inhibitors (Complete
mini, Roche) in PBS or EBC200 buffer (50 mM Tris–HCl (pH 8), 0.2 M
NaCl, 0.5% NP-40, 0.1 M NaF, 0.2 mM Na3VO4, and protease inhibitors) on
ice for 30 min. The lysates were collected and cleared by centrifugation at
14,000×g for 10 min at 4°C. Total protein concentration in the lysates was
determined using the BioRad DC protein assay. 500 μg of lysate total protein
was immunoprecipitated with protein G-sepharose beads (Sigma) overnightConditions
A-3′ 96° 5 m; 35 cycles: 96° 1 m, 55° 1 m, 72° 1 m; 72° 5 m
C-3′
C-3′ 96° 5 m; 35 cycles: 99° 1 m, 55° 1 m, 72° 1 m; 72° 5 m
A-3′
′ 96° 5 m; 40 cycles: 96° 1 m, 48° 1 m, 72° 1 m; 72° 5 m
A-3′ 95° 5 m; 35 cycles: 95° 30 s, 54° 30 s, 72° 1 m; 72° 5 m
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1 μg α-myc antibody (mouse monoclonal, Sigma). The beads were pelleted
and washed three times in either cold PBS (if PBS lysis buffer used) or cold
NETN (if EBC200 used; 20 mM Tris (pH 8), 0.1 M NaCl, 1 mM EDTA, 0.5%
NP40) and then resuspended in SDS-loading buffer. Bound proteins were
eluted by boiling, resolved by SDS-PAGE, and Western blotted. The blots
were blocked and incubated in PBS containing 3% milk and α-Nkx2.2
antibody 1:100 (goat polyclonal, Santa Cruz) for 1–4 h. After two 10-min
washes in PBS, the blots were incubated in alkaline phosphatase-conjugated
secondary antibody 1:2500 (Sigma) in PBS/3% milk for 1–2 h. For detection
of bound proteins, the blots were washed twice in PBS for 10 min, rinsed in
water, and then incubated in BM Purple (Roche).
Luciferase assays
Luciferase assays were performed as described (Kathiriya et al., 2004).Results
Gata6 and Gata4 are expressed in the embryonic mouse
pancreas
To begin to ascertain whether Gata factors are involved in the
development of the embryonic mouse pancreas, we first
determined which of the known mouse Gata family members
are expressed during pancreas development. RNA in situ hy-
bridization using RNA probes specific for each of the six Gata
transcription factors was performed on frozen sections of e12.5
embryos. Our analysis shows that mRNA for Gata4 and Gata6 is
expressed in the developing pancreas (Fig. 1). mRNA could not
be detected for Gata1, Gata2, Gata3, or Gata5 in the pancreas,
although we detected strong expression of these genes in other
organs including the kidney, liver, and brain (Fig. 1 and data not
shown). We performed RNA in situ hybridization at additional
developmental stages between e9.5 and e16.5. This time period
encompasses both initial pancreas specification (∼e9.5) and the
secondary transition (∼e12.5–e15.5), a stage of extensive ex-
pansion and differentiation of the pancreatic epithelium. Gata4
and Gata6 expression is maintained throughout these stages ofFig. 1. In situ hybridization of e12.5 tissue using antisense RNA probes for each G
expressed in the embryonic mouse pancreas (d, f). Gata1, Gata2, Gata3, and Gata5 are
dashed line.pancreas development (Figs. 1–3 and data not shown). To
confirm the RNA in situ hybridization results and rule out the
possibility that Gata1, Gata2, Gata3, and Gata5 are expressed at
levels below detection by non-radioactive RNA in situ hybrid-
ization, we performed RT-PCR on an e12.5 pancreas cDNA
library using gene-specific primers for each of the six Gata factor
family members. In addition, we assessed expression data
previously generated from Affymetrix microarray analyses of
cDNA generated from e12.5 pancreas RNA (Prado et al., 2004).
Consistent with the RNA in situ hybridization expression data,
Gata4 and Gata6 mRNA was strongly detected in the e12.5
pancreas, but Gata1, Gata2, Gata3 or Gata5 mRNA was not
present (data not shown).
Gata4 and Gata6 expression becomes restricted to distinct
pancreatic lineages at later developmental stages
To further characterize the spatial and temporal expression of
Gata4 and Gata6 within the developing pancreas, we compared
expression of Gata4 mRNA, Gata4 protein, and Gata6 mRNA
with the expression of pancreatic cell type-specific markers at
different embryonic stages. We were unable to analyze Gata6
protein expression because a reliable Gata6 antibody is not
available. In contrast to previous studies (Ketola et al., 2004),
our analysis shows that both Gata4 and Gata6 are expressed
throughout the pancreatic epithelium at e9.5, when the pancreas
first begins to form. Gata4 mRNA is expressed from the onset of
dorsal bud evagination and overlaps extensively with Pdx1 (Fig.
2a). In addition, immunofluorescence studies demonstrate that
Gata4 protein is detected throughout the pancreatic epithelium at
e9.5 but is absent from glucagon-expressing cells (Fig. 2b),
suggesting that Gata4 is excluded from endocrine cells at the
earliest stage of pancreas development. Gata4 mRNA is
observed in most pancreatic epithelial cells by e11.5 (data not
shown), but expression progressively moves toward the tips of
the branching ducts (i.e., the presumptive acini) as development
proceeds (Fig. 2c, inset). By e16.5, Gata4 protein expression isata transcription factor family member reveals that only Gata4 and Gata6 are
not expressed in the developing mouse pancreas (a–c, e). Pancreas outlined with
Fig. 2. Gata4 mRNA and protein expression analysis. At e9.5, Gata4 RNA (blue, a) and protein (green, b) are expressed globally in the pancreatic epithelium along
with Pdx1 (brown; a) and glucagon (red; b). By e16.5, Gata4 expression becomes restricted to the exocrine pancreas (red, c; green, d), where it is coexpressed with
amylase (green, c) but not with glucagon (red, d). Gata4 is expressed (red) in the nucleus of cells that express amylase (green) in the cytoplasm (c, inset). Gata4 (green)
is co-expressed with a subset of insulin cells (red) in the adult islet (e). Gata4 (green) is coexpressed with amylase (red) in the AR42J exocrine cell line (f, g, h).
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nucleus of cells expressing amylase and carboxypeptidase A
(Fig. 2c and data not shown). However, Gata4 is excluded from
both the ducts and developing islets, and is not found in cells
expressing glucagon (Fig. 2d and data not shown). At all stages
of embryonic pancreas development, the pattern of Gata4
protein expression is consistent with the pattern of Gata4 mRNA
expression and Gata4 protein is localized to the nucleus. By
e18.5, a subset of acini continues to express Gata4 (data not
shown). Our in vivo results are supported by immunofluores-
cence analysis in the AR42J exocrine pancreas cell line,
confirming that Gata4 is present in cells also expressing the
exocrine enzyme amylase (Figs. 2f–h). Interestingly, in the adult
pancreas, Gata4 is expressed in a subset of α and β cells of the
adult islet, but is no longer detectable in the exocrine tissue (Fig.
2e and data not shown). Nuclear and non-nuclear expression of
Gata4 can be detected in the adult islet.
Similar to Gata4, Gata6 mRNA is expressed globally in the
e9.5 dorsal pancreatic bud and is co-expressed with Pdx1 (Fig.
3b). In contrast to Gata4, Gata6 mRNA is expressed in cells also
expressing glucagon at this stage (Figs. 3a and b). As develop-
ment proceeds, Gata6 expression becomes restricted to cells of
the endocrine pancreas and the ductal epithelium (Fig. 3c). By
e12.5, Gata6 is expressed throughout the differentiating
pancreatic epithelium in regions similar to endocrine transcrip-
tion factor Nkx2.2 (Figs. 3d and e) and a marker of endocrineprogenitor cells, Ngn3 (Figs. 3e and f). During the secondary
transition, glucagon is coexpressed in some, but not all cells that
express Gata6 (Figs. 3g and h). Between e14.5 and e15.5, Gata6
mRNA is expressed strongly in the pancreatic epithelial ducts
and becomes down-regulated in cells differentiating into acini
(Fig. 3i).
Nkx2.2 physically interacts with Gata6, but not Gata4
Gata4 and Gata6 are known to interact with tissue-specific
transcription factors to regulate genes expressed during the
differentiation of numerous embryonic tissues. We originally
pursued our analysis of the Gata factors in the pancreas due to
the close link between Gata factors and Nkx2 factors in the
development of several different organs (Stennard et al.,
2003). Early in pancreas development, expression of Gata4
and Gata6 overlaps with Nkx2.2, a transcription factor known
to be essential for normal pancreas development (Prado et al.,
2004; Sussel et al., 1998). Later in development, only Gata6 is
coexpressed with Nkx2.2 in endocrine cells of the islet. To
determine whether Gata4 and/or Gata6 are able to interact with
Nkx2.2, we performed a series of yeast two-hybrid assays in
which a derivative of Nkx2.2 that lacks its two activation
domains (see Materials and methods) was fused to the GAL4
DNA binding domain and used as bait (BD-Nkx2.2). Chimeric
proteins containing full-length Gata4 and Gata6 fused to the
Fig. 3. Gata6 mRNA expression analysis. At e9.5, Gata6 mRNA (blue) is expressed globally throughout the pancreatic epithelium, along with Pdx1 (brown, b) and
glucagon (green, a); a and b are adjacent sections. By e14.5, Gata6 mRNA is highly expressed in the pancreatic epithelium (c). At e12.5, Gata6 mRNA expression
overlaps with the endocrine transcription factors Nkx2.2 and Ngn3 (d–f). Images d–f represent near adjacent sections. At e12.5, Gata6 mRNA (blue, h) is expressed in
some, but not all cells that express glucagon (green, g); g and h represent the same section; Gata6 in situ analysis was performed first, followed by immunofluorescence
with the α-glucagon antibody. Gata6 mRNA (blue) is localized to the ducts at e14.5 and becomes extinguished from amylase-expressing (brown) exocrine cells as they
bud from the duct (i).
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co-activate GAL4 UAS-lacZ with BD-Nkx2.2. As shown in
Supplemental Fig. 1a, BD-Nkx2.2 alone or in combination
with AD-Gata4 is incapable of activating GAL4 UAS-lacZ,
whereas coexpression of BD-Nkx2.2 with AD-Gata6 results in
the activation of lacZ expression. Furthermore, coexpression
of BD-Nkx2.2 with a C-terminal truncation of AD-Gata6
(pACT:Gata6-N-terminal), which deletes the zinc finger
domain and the C-terminal extension required for interaction
between Gata4 and Nkx2.5 (Durocher et al., 1997), prevented
the interaction and failed to activate lacZ expression. These
results suggest that Gata6, but not Gata4, interacts with
Nkx2.2.
We confirmed the physical association of Gata6 and Nkx2.2
using in vitro pull down assays and co-immunoprecipitation
assays of mammalian cell extracts. Full-length Nkx2.2 was
fused with maltose binding protein (MBP) to generate MBP-
Nkx2.2. Immobilized MBP-Nkx2.2 retained 35S-labeled Gata6,
whereas immobilized MBP alone did not (Supplemental Fig.1b). Co-immunoprecipitation was performed on whole cell
extracts from COS-7 cells transfected with Gata6 and myc-
tagged Nkx2.2, individually or in combination. Immunopreci-
pitation of extracts using α-Gata6 antibody or α-myc antibody
followed by Western blotting for Nkx2.2 confirmed that Nkx2.2
interacts with Gata6 in vivo (Supplementary Fig. 1c). These
results suggest that Nkx2.2 and Gata6 may cooperate in the
regulation of early pancreas or islet specific gene expression,
similar to Nkx2.5 and Gata4 cooperativity in heart-specific gene
expression (Durocher et al., 1997; Sepulveda et al., 1998). We
are currently attempting to identify direct targets of Nkx2.2 and
Gata6 in the islet.
Production of Gata dominant repressor transient transgenic
mice
The dynamic expression patterns of Gata4 and Gata6 in the
pancreas, combined with the physical interaction between
Nkx2.2 and Gata6, suggest that Gata4 and Gata6 may have
Table 2
Summary of transgenic phenotypes
Phenotype Class I Class II Class III
Pdx1:G6FLEnR 3 2 0
Pdx1:G6DBDEnR 0 1 0
Pdx1:G4FLEnR 0 1 7
421K. Decker et al. / Developmental Biology 298 (2006) 415–429overlapping functions during the initial specification of the
embryonic mouse pancreas, but may be uniquely involved in the
differentiation of endocrine cell types (Gata6) or exocrine cell
types (Gata4). To investigate whether Gata factors play a
functional role in the developing mouse pancreas, we utilized a
dominant repressor transient transgenic mouse system modeled
after experiments assessing the role of Gata6 in lung develop-
ment (Koutsourakis et al., 2001; Liu et al., 2002b; Yang et al.,
2002). As illustrated in Supplemental Fig. 2 and described in
Materials and methods, we designed two Gata6 dominant
repressor transgenes (Pdx1:G6FLEnR and Pdx1:G6DBDEnR),
one Gata4 dominant repressor transgene (Pdx1:G4FLEnR), and
one control transgene (Pdx1:NLSEnR). Based on the previous
studies, we predicted that fusion of the Engrailed repression
domain to full-length Gata4 or Gata6 would repress genes
normally activated by Gata4 and Gata6, respectively. Further,
since the DNA binding domains of Gata4 and Gata6 are highly
conserved at the DNA and protein levels, we hypothesized that
fusion of the Engrailed repressor domain to the Gata6 DNA
binding domain would result in repression of all Gata4 and
Gata6 target genes. The control transgene, Pdx1:NLSEnR, was
not expected to affect pancreas development, similar to the
findings of Yang et al. (Yang et al., 2002) who expressed an EnR-
only control transgene in the lung epitheliumwithout phenotypic
consequences. Expression of each fusion protein is driven by the
4.5 kb Pdx1 promoter element, which is active starting at e8 in
the developing endoderm and becomes restricted to the
developing pancreas around e9 (Gannon et al., 2000; Norgaard
et al., 2003). The Pdx1 promoter is well characterized, reca-
pitulates endogenous Pdx1 expression which is largely pan-
creas-specific, and mirrors the early pancreas expression pattern
of Gata4 and Gata6 (Apelqvist et al., 1997; Li and Edlund, 2001;
Stoffers et al., 1999). While later stage expression of Pdx1 is
predominantly restricted to the endocrine pancreas (similar to
Gata6), Pdx1 is also expressed at lower levels in exocrine cells
and is required for proper differentiation of these cell types (Hale
et al., 2005).
Transient transgenic mice carrying each of the Gata
derivatives or the control were generated after several attempts
to establish stable mouse lines proved unsuccessful. We chose
to analyze transient transgenic embryos due to the possibility
that the Gata transgenes were significantly disrupting pancreas
development, resulting in neonatal lethality. Pregnant mice
were sacrificed and embryos were harvested between 15.5 and
17.5 days following pronuclear injection. For each of the four
transgenes, phenotypic analysis was performed on transgenic
and wildtype littermates. For this study, we generated twenty-
five embryos which carried a transgene and assessed transgene
expression by RNA in situ analysis on sectioned pancreatic
tissue. Of these, two Pdx1:G6FLEnR, one Pdx1:G6DBDEnR,
one Pdx1:NLSEnR (control), and eight Pdx1:G4FLEnR
embryos expressed the transgene. Three additional Pdx1:
G6FLEnR embryos exhibited a dramatic “absence of pan-
creas” phenotype (see below); assessment of transgene
expression in the absent tissue was not possible. Injected em-
bryos that did not contain the transgene were used as littermate
controls.Analysis and classification of Gata dominant repressor
transient transgenics
To assess whether the Gata dominant repressor transgenes
affect development of the embryonic mouse pancreas, we first
performed histological analysis of the late stage embryos.
Frozen sections from transgenic and wildtype embryos were
stained with hematoxylin and eosin (H&E). As summarized in
Table 2, we observed three distinct pancreatic phenotypes in the
transgenic embryos: absence of pancreas (hereafter referred to as
Class I); severely disrupted pancreas morphology (Class II); and
little to no observable phenotype (Class III). All transgenic
embryos exhibited overall normal morphology of non-pancrea-
tic tissue. Three Pdx1:G6FLEnR embryos exhibited a Class I
defect, completely lacking a pancreas or any recognizable pan-
creatic rudiment. Two Pdx1:G6FLEnR embryos and the Pdx1:
G6DBDEnR embryo had Class II defects. A Class III phenotype
was not observed for any Gata6 transgenic embryo. Interest-
ingly, only one Pdx1:G4FLEnR transgenic embryo displayed
disrupted islet morphology, while seven Pdx1:G4FLEnR
transgenic embryos had no observable phenotype despite strong
transgene expression (Fig. 7). The Pdx1:NLSEnR embryo had
normal pancreas morphology and no apparent phenotype (Fig. 4i
and data not shown).
The pancreas is absent in Class I Gata6 repressor transgenics
Following initial analysis and classification of the transgenic
embryos, a more thorough investigation of the Pdx1:G6FLEnR
and Pdx1:G6DBDEnR phenotypes was pursued. Strikingly, in
three independent e17.5 Pdx1:G6FLEnR transgenic embryos,
pancreas formation appeared to be completely disrupted (Class I
phenotype; Figs. 4b–d). Although there was no morphological
evidence of the pancreas, it was important to determine whether
any pancreatic rudiments or cell types had formed, as seen in
Pdx1 null mice (Offield et al., 1996), or whether there were
ectopic islet cells, as observed in Ptf1a null mice (Krapp et al.,
1998). Tissue sections throughout each of the three Class I Gata6
transgenics were analyzed with a panel of diagnostic pancreatic
markers to ascertain whether pancreatic rudiments were present
anywhere within these Pdx1:G6FLEnR embryos. Using immu-
nohistochemical analysis, we were unable to detect expression
of amylase, insulin, glucagon, somatostatin, PP, or ghrelin (data
not shown). Furthermore, we were unable to detect pancreatic
expression of the markers Pdx1 and Ptf1a (data not shown),
although Pdx1 was still expressed in the duodenum and stomach
(Fig. 4d). In addition, we did not detect pancreatic expression of
Ngn3, Nkx2.2, Nkx6.1, or Pax6, although these transcription
factors were still expressed in non-pancreatic tissues (data not
Fig. 4. Histological analysis of Gata6 transgenic mice. H&E stained sections of
an e17.5 Pdx1:G6FLEnR wildtype littermate (a) and two e17.5 Pdx1:G6FLEnR
transgenic littermates with a Class I (no pancreas) phenotype (b, c). One embryo
exhibited morphological evidence of endodermal-like epithelium (c, arrows);
however, this tissue did not express pancreatic markers. In situ hybridization
using a Pdx1 RNA probe shows that duodenum formation is not disrupted in
Class I transgenic embryos (d). Endocrine, exocrine, and ductal pancreas
morphology is severely disrupted in Class II Pdx1:G6FLEnR and Pdx1:
G6DBDEnR transgenic embryos (e, g). Excess mesenchymal tissue surrounds
the enlarged duct of one Class II transgenic embryo (g, arrows). Morphology of
the pancreas is normal in Pdx1:NLSEnR control embryos (i). In situ
hybridization using an RNA probe for Engrailed reveals Gata6-repressor
transgene expression in embryos with a Class II phenotype (f and h) and
expression of the transgene in Pdx1:NLSEnR controls (j). Scale bar is 500 μm
for panels a–d and i–j. Scale bar is 100 μm for panels e–h. l, liver; i, intestine; k,
kidney; s, stomach; d, duodenum. Pancreas outlined with dashed line; dashed
line in b indicates expected location of pancreas in Class I transgenic.
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pancreas initially formed and subsequently degenerated, our
analyses suggest that no pancreatic rudiments or cell types have
formed in the Class I Pdx1:G6FLEnR embryos.Pancreas development is disrupted in the second class of
Gata6 repressor transgenics
In another subset of Pdx1:G6FLEnR and Pdx1:G6DBDEnR
embryos we observed a second phenotypic class in which there
was a severe loss of differentiated pancreas cell types although a
small amount of pancreatic tissue remained (Class II phenotype;
Figs. 4e and g). Class II transgenic embryos form both the dorsal
and ventral pancreatic domains; however, there is less overall
pancreatic tissue and islets are not properly formed (Figs. 5b, d, f
and h). In addition, fewer acini are present and some embryos
display a disruption of acinar cell morphology that correlates
with a reduction in enzyme expression (Fig. 5d, arrow). Interest-
ingly, a phenotypic difference was not observed between Class II
Pdx1:G6FLEnR embryos and the Pdx1:G6DBDEnR embryo. In
addition, the phenotype was similar in each of the Class II
embryos and we did not observe a gradient of phenotypes
between the Class I and Class II phenotypes, suggesting that
Gata6 may function at two discrete stages in pancreatic deve-
lopment (see Discussion).
To explore the possibility that the less severe phenotype
associated with the Class II Gata6 transgenic mice is due to
weaker or mosaic expression of the transgene, we performed in
situ hybridization using an RNA probe for the Engrailed portion
of the transgene in these embryos. Strong expression of the
transgene was detected in differentiated regions of the pancreas
in all Pdx1:G6FLEnR and Pdx1:G6DBDEnR embryos with a
Class II phenotype (Figs. 4f and h, and data not shown). Similar
to the Class I embryos, transgene expression could no longer be
detected in undifferentiated regions of the pancreas, regions that
had differentiated into exocrine cells, or tissue that appeared
more mesenchymal in structure (Figs. 4g and h). It remains
possible that timing or initiation of transgene expression may be
affecting the phenotype; however, this cannot be explored in
transient transgenic embryos.
Class II Gata6 repressor embryos have fewer differentiated
cells
Histological analysis of the Class II Gata6 embryos suggested
that few differentiated pancreatic structures had formed. To
assess the degree to which cell differentiation was disrupted in
these mice, we performed immunofluorescence to detect the
presence and localization of exocrine enzymes and endocrine
hormones. Exocrine tissue is clearly present; however, the
relative numbers of acini clusters are reduced concomitant with a
reduction in amylase expression (Fig. 5d). Furthermore, there
appear to be acini clusters that express reduced levels of amylase
(Fig. 5d, arrows). In addition, these embryos lack the well-
formed islets normally seen at this stage of development, and
have a significant reduction in the number of cells expressing
insulin (Figs. 5b, d, f, h, and i), glucagon (Figs. 5b and i),
somatostatin (Fig. 5f), and ghrelin (Fig. 5h). The hormone-
producing cells that are present tend to be scattered throughout
the pancreas and around the ductal tissue. To quantify the loss of
insulin and glucagon cells in the Class II embryos, we quantified
insulin-positive and glucagon-positive cells from two
Fig. 5. Immunohistochemical staining for pancreatic hormones and enzymes. In
comparison to the pancreas of the wildtype littermate (a, c, e, and g), Class II
transgenic embryos have reduced numbers of cells expressing insulin (b, d, f,
and h), glucagon (b), amylase (d, arrows) somatostatin (f) and ghrelin (h,
arrows). Scale bar 100 μm. There was a >3-fold reduction in the number of
insulin-expressing cells (p<0.001) and an approximately 4-fold reduction in the
number of glucagon-expressing cells (p<0.001) when comparing wildtype and
Class II littermates (i). Insulin-positive and glucagon-positive cells were counted
on ten sections each from two wildtype and two Class II transgenic embryos.
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wildtype littermates. This analysis revealed a 3- to 4-fold
reduction in the number of insulin-expressing and glucagon-
expressing cells in the Gata6 transgenic embryos (Fig. 5i).Traditional morphometric analysis of the islet was not possible
due to the severe disruption of general pancreas and islet
morphology.
In comparison to wildtype littermates, Class II Gata6
transgenic embryos also display aberrant development of the
ductal epithelium (Figs. 6b, d and e; Figs. 4g and h). Ducts in a
Class II embryonic pancreas are generally larger, greater in
number, and morphologically abnormal compared to ducts in a
typical e17.5 pancreas. To determine whether the ducts of Class
II embryos were epithelial in nature, we performed immuno-
fluorescence using a fluorescein-conjugated antibody against
DBA-Lectin, a marker of pancreatic ductal epithelium. In the
wildtype littermate, DBA-Lectin marks discrete areas of ductal
epithelia that permeate throughout the pancreas (Fig. 6c). By
contrast, in the Class II embryos, DBA-Lectin delineates greatly
enlarged ducts that are epithelial in nature (Figs. 6d and e).
Interestingly, DBA-Lectin is not expressed in all duct cells in
these embryos (Fig. 6d, arrow). In some cases, the epithelia of
these oversized ducts are surrounded by a stratified cell type
(Fig. 4g, arrows) that express the mesenchymal marker,
Vimentin (data not shown). In wildtype embryos, pancreatic
mesenchyme is significantly reduced by e17.5.
In Class II embryos, we also observe a significant reduction
in the overall numbers of endocrine cells and a large proportion
of the cells that remain are localized to the ducts (Figs. 6d and e;
Fig. 5f). Occasionally, cells that express the ductal marker
DBA-Lectin also express hormones, such as insulin (Fig. 6d
inset). Potentially, these cells represent an endocrine progenitor
cell population. To determine whether Class II embryos
maintain a larger pool of endocrine progenitors than wildtype
littermates, we performed RNA in situ hybridization to analyze
expression of Ngn3, a transient marker of all endocrine
progenitor cells. By e17.5 in a wildtype embryo, the endocrine
progenitor population has decreased to a low level and few cells
express Ngn3 (Fig. 6f, arrows). In comparison, Class II embryos
show an apparent increase in the number of Ngn3-expressing
endocrine progenitor cells, despite a clear reduction in
pancreatic mass (Fig. 6g). However, due to loss of overall
pancreatic tissue and significant disruption to pancreas
morphology in the Class II embryos, it is unclear whether this
increase is statistically significant.
To further investigate the differentiation state of the
pancreatic islet cell types in Class II Gata6 embryos, we ana-
lyzed expression of the transcription factors Pdx1, Nkx6.1, and
Pax6. Pdx1 is normally expressed in endocrine progenitors
along with mature β and δ cells (Guz et al., 1995; Ohlsson et al.,
1993). Nkx6.1 is expressed in duct cells as well as terminally-
differentiated β cells, while Pax6 is expressed in all mature
endocrine cell types (Sander et al., 1997; Sander et al., 2000; St-
Onge et al., 1997). Consistent with the reduction in total
pancreatic islet tissue, there is a reduction in the numbers of cells
expressing these transcription factors in the transgenic embryos
(Supplementary Figs. 3b, d, and f). In addition, cells expressing
these transcription factors in the Class II embryos are often
localized to the periphery of the ducts (Supplementary Figs. 3d
and f). For example, the majority of Nkx6.1-expressing cells are
within the ductal epithelium in Class II embryos (Supplementary
Fig. 6. Analysis of aberrant duct development. H&E staining (a, b); immunofluorescence staining of insulin (red) and the ductal marker DBA-Lectin (green, c–e). In
comparison to the wildtype littermate (a, c), Class II transgenic embryos display aberrant and enlarged duct development (b, d, e). Some cells of the enlarged ducts do
not stain for the ductal marker DBA-Lectin (d, arrow). Of the few endocrine cells that differentiate in the Class II embryos, many are localized to the ducts (d and e;
inset in d). RNA in situ analysis of Ngn3 (f, g). Class II embryos display increased numbers of Ngn3+ cells (g) in comparison to wildtype littermates (f). Ngn3 staining
was performed on two sections each from two wildtype and two Class II transgenic embryos. Scale bar 100 μm.
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another, we also analyzed Gata4 expression in Class II Gata6
embryos by performing immunofluorescence using an α-Gata4
antibody. Although the total number of exocrine cells is reduced,
Gata4 expression is maintained in the nucleus of these cells (data
not shown).
The loss of pancreatic mass in the Class II Gata6 transgenics
could be due to a block in cell differentiation, a reduction in cell
proliferation, and/or an increase in cell death. To determine if
there are any abnormalities in cell death or proliferation, we
compared levels of apoptosis and cellular proliferation between
transgenic and wildtype embryos. We observed no change in the
level of cell death in Class II or Class I embryos, as determined
by TUNEL assay at e17.5 (data not shown); however, these
embryos have such an extreme loss of pancreatic tissue by e17.5
that it is possible there is substantial cell death at an earlier
period, which is difficult to assess in the transient transgenic
system. We also performed immunohistochemical analysis
using an antibody against phospho-Histone H3, which marks
cells in M phase, and determined that there is no significant
difference in the proliferative state of pancreatic cell types
between the wildtype and Class II transgenic littermates (data
not shown). The absence of obvious proliferative defects or
increased cell death at e17.5 supports our previous findings that
suggest Pdx1:G6FLEnR and Pdx1:G6DBDEnR may cause adisruption of pancreatic cell differentiation, however, we cannot
rule out that increased cell death or decreased proliferation
occurred at time points prior to our analysis at e17.5.
The majority of Pdx1:G4FLEnR transgenic embryos do not
display disrupted pancreas morphology or development
Both Gata4 and Gata6 are expressed globally throughout the
pancreatic epithelium at the earliest stages of pancreas devel-
opment, but their expression becomes restricted to mutually
exclusive domains at later stages of development. Consequently,
it was possible the Pdx1:G4FLEnR transgene would produce
phenotypes that affect early pancreas development as well as
differentiation of exocrine cell types. We analyzed eight Gata4
transgenic embryos along with their wildtype littermates. RNA
in situ hybridization to detect the Engrailed portion of the
transgene demonstrated that all eight Gata4 transgenic embryos
strongly express the Gata4 dominant repressor transgene (Figs.
7c, f, and data not shown). Surprisingly, in contrast to the Gata6
transgenics, most of the Gata4 transgenic embryos appear to be
phenotypically normal (Fig. 7e) with no obvious defects in
endocrine hormone, exocrine enzyme, and pancreatic transcrip-
tion factor expression (data not shown). To ensure that the
G4FLEnR construct was functional, we assessed its ability to
interfere with Gata4 transcriptional activation. Since Gata4 has
Fig. 7. Analysis of Gata4 transgenic embryos. H&E staining (a, b, d, e). RNA in situ analysis of transgene expression (c, f). One Pdx1:Gata4FLEnR transgenic embryo
exhibited a Class II phenotype (b) in comparison to its e16.5 wildtype littermate (a). The Class II transgenic embryo expressed the Gata4-repressor transgene at
significant levels throughout the pancreas (c). Seven Pdx1:Gata4FLEnR transgenic embryos were morphologically normal (e) compared to their wildtype littermates
(d), despite expression of the Gata4-repressor transgene (f). Scale bar 100 μm.
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heavy chain gene (αMyHC) (Molkentin et al., 1994; Kathiriya et
al., 2004) we determined that the G4FLEnR fusion protein is
able to effectively block Gata4-dependent activation of an
αMyHC-luciferase reporter in HeLa cells (Supplementary Fig.
4). This suggests the G4FLEnR fusion protein is functional in an
in vitro reporter assay, however we cannot rule out that the Gata4
dominant repressor transgene is less effective in the pancreas in
an in vivo context. One Gata4 transgenic embryo exhibited a
phenotype similar to the Class II Gata6 transgenic embryos:
there is a reduction in the mass of exocrine and endocrine tissue
and a corresponding loss of hormone and enzyme expression
(Fig. 7e and data not shown). This phenotype may be due to off-
target effects of the G4FLEnR transgene. Conditional knockout
analysis of Gata4 in the pancreas will help resolve this issue.
Discussion
Gata factor family members are required for the proper
development of many essential cell types, tissues, and organs in
vertebrates (Patient and McGhee, 2002). The objectives of this
study were to determine which Gata factors are expressed in the
embryonic mouse pancreas and whether Gata factors play a
functional role during pancreas development. Our analyses
demonstrate that Gata4 and Gata6 are expressed at the onset of
pancreas development throughout the pancreatic epithelium. As
development proceeds, Gata6 becomes restricted to the endo-
crine pancreas and ducts, while Gata4 becomes restricted to the
exocrine pancreas. Other Gata factor family members could not
be detected in the developing pancreas. Using a dominant
repressor transgenic approach that has proven successful in the
analysis of Gata function in lung development, we determined
that Gata6 plays a predominant role in the initial specification of
the pancreas and in pancreatic cell type differentiation.Consistent with this finding, we demonstrated that Gata6 physi-
cally interacts with the essential pancreatic transcription factor,
Nkx2.2. These studies are the first to demonstrate the importance
of Gata6 function in the vertebrate pancreas.
Gata4 and Gata6 are dynamically expressed in the developing
pancreas
The results of the Gata4 and Gata6 expression analysis
performed in this study are largely consistent with a previous
study that reported Gata6 expression in the endocrine pancreas
and Gata4 expression in the exocrine pancreas during mouse
embryogenesis (Ketola et al., 2004). However, we also
revealed overlapping expression domains for Gata4 and
Gata6 in the early pancreatic epithelium. In support of our
findings, Chiang and Melton (Chiang and Melton, 2003)
reported Gata4 and Gata6 expression in RNA isolated from
total e12.5 pancreas and in almost every individually isolated
e10.5 pancreatic cell assayed. Gata5 was detected in a small
number of the individually isolated e10.5 pancreatic cells;
however, we were unable to detect significant Gata5
pancreatic expression in any of our assays. Both our results
and the Ketola study conflict with the study of Ritz-Laser et
al. (Ritz-Laser et al., 2005) that suggests Gata4 is expressed in
the developing endocrine pancreas and activates glucagon
gene expression. We were unable to detect coexpression of
Gata4 and glucagon at any time during embryonic develop-
ment. We do observe Gata4 expression in the islet of adult
mice, where it is coexpressed with a subset of glucagon-
expressing cells. This may indicate that Gata4 regulates
glucagon in the adult islet. Consistent with our expression
data, we do not observe an effect on glucagon expression in
the embryonic islet for the majority of the embryos expressing
a Gata4-repressor transgene. We are currently following up
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delete Gata4 from the embryonic α cells and assess how this
affects glucagon gene expression.
Disruption of Gata6, but not Gata4, function causes abnormal
pancreatic development
The strong and dynamic expression patterns of Gata4 and
Gata6 suggested that they may both function in pancreatic
development. We predicted that Gata4 and Gata6 might function
redundantly at early stages of pancreas formation when their
expression overlaps, but that Gata4 would function specifically
in the differentiation of exocrine cells and that Gata6 would be
involved in the differentiation of endocrine cells. Surprisingly,
several full-length Gata6-EnR transgenics completely blocked
pancreas formation, indicating that Gata6 may function non-
redundantly in early pancreatic specification. In addition, two
Gata6 transgenic embryos and the Gata6DBD transgenic
embryo severely disrupted pancreatic cell development.
An unexpected result from these studies was the finding that
all but one of the Gata4 transgenics did not have an overt
pancreatic phenotype, suggesting that Gata4 is not required for
early pancreatic specification. In the majority of the Gata4
transgenic embryos, we also did not observe a defect in the
development and differentiation of the exocrine acinar cells.
However, a caveat of these studies is the use of the Pdx1
promoter to drive expression of the Gata4 transgene. Although
Pdx1 is required for exocrine cell differentiation, it is only
expressed at low levels in the acinar cells. Therefore, it remains
possible that expression levels of the Gata4 transgene are not
sufficient to interfere with endogenous Gata4 activity in the later
stage pancreas. Recent functional analysis of Gata4 in zebrafish
has demonstrated that Gata4 is required for the formation of
many organs, including the liver, intestine, and pancreas.
Interestingly, Gata4 morphant embryos are able to initiate
endocrine pancreas budding, but have specific defects in
exocrine pancreas development (Holtzinger and Evans, 2005).
In light of the zebrafish studies, we cannot eliminate the pos-
sibility that Gata4 functions at some point during exocrine
development.
Of note, one Gata4 transgenic embryo did display a disrupted
pancreatic phenotype similar to the Class II Gata6 transgenics. It
is possible that this single embryo reveals a role for Gata4 in
pancreas development that is not observed in the other Gata4
transgenics due to differences in timing or levels of transgene
expression caused by position effect. However, a dispropor-
tionate number of Gata4 transgenic embryos do not have an
obvious phenotype, although they express the transgene in
comparatively similar expression domains and at equal or higher
levels than the Class II Gata4 transgenic embryo. We are unable
to assess the onset of transgene expression in our transient
transgenic system, so this issue remains unresolved. An alter-
native explanation is that the Gata4 transgene interferes with
Gata6 function in the single Class II Gata4 embryo. Several
studies in cardiomyocytes have demonstrated that Gata4 and
Gata6 bind to similar DNA consensus sequences (Charron et al.,
1999). In addition, due to Gata4 and Gata6 overlappingexpression patterns and variable or absent phenotypes in
mouse knockout studies, there has been ongoing speculation
that these proteins can partially compensate for each other during
heart development. Therefore, it is possible that the Gata4
transgene could interfere with Gata6 activity. However, it is
unclear why this phenotype is observed infrequently.
Gata6 repressor disrupts two discrete stages of pancreatic
development
Expression of the Gata6 dominant repressor transgenes
results in two distinct phenotypes, allowing us to evaluate how
Gata6 functions during early and late stages of pancreas
development. Examples of phenotypic diversity are well-
documented in experimental transgenic systems and may be
related to the specific site of integration as well as number of
transgene copies. Phenotypic variation has also been observed in
Gata mutational, knockdown, and knockout analyses. In
zebrafish, there is considerable variation in the phenotypes of
the faust (Gata5) and Gata6 morphant embryos, which either
completely lack myocardial tissues or have minor myocardiac
phenotypes (Heicklen-Klein et al., 2005; Peterkin et al., 2003;
Reiter et al., 2001). While the majority of Gata4 null mice die at
gastrulation, 60–70% of the Gata4 null mice that survive
gastrulation are able to form normal differentiated myocardium
and the remainder have defects in myocardial differentiation
(Kuo et al., 1997; Molkentin et al., 1997). The observed
phenotypic differences may be due to partial compensation by
other Gata factors. Alternatively, evidence is accumulating that
members of the Gata transcription factor family may establish
and regulate chromatin domains to control cell type differentia-
tion (Bresnick et al., 2005; Martowicz et al., 2005). It is possible
that a threshold of Gata activity is required to regulate chromatin,
and in some embryos, this threshold can be reached even in the
absence of a particular Gata factor. In these embryos,
development will proceed normally until the next Gata-
dependent regulatory time point is encountered. Once transcrip-
tional targets of Gata6 have been identified in the pancreas, we
will be able to more precisely assess the mechanism of Gata
function.
Three of the Pdx1:G6FLEnR transgenic embryos analyzed
did not form a pancreas, suggesting that Gata6 is required for
the initial specification of the embryonic mouse pancreas. The
block in pancreas development does not appear to be caused
by an early foregut endoderm defect because the duodenum,
which arises from foregut endoderm adjacent to the pancreas
and also expresses Pdx1, appears to develop normally in these
mice (Fig. 4d). Furthermore, recent studies in mouse using a
tetraploid complementation approach to rescue Gata6 function
in extra-embryonic tissues demonstrate that general specifica-
tion of ventral endoderm does not require Gata6 (Zhao et al.,
2005). In zebrafish, Gata6 morphant studies result in a
complete block of liver development; however, the endodermal
markers FoxA2 and Sox17 are expressed normally which
indicates that Gata6 is not involved in general endoderm
specification (Holtzinger and Evans, 2005). Pancreas forma-
tion was not assessed in the zebrafish study. By e17.5 in
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stomach and the intestine while the ventral pancreas is found
adjacent to the liver. Analysis of the Pdx1:G6FLEnR embryos
that lacked pancreatic tissue demonstrated that these regions
were compacted and largely devoid of recognizable tissues or
structures. However, in two of the embryos there appear to be
small patches of undifferentiated epithelium that resembled
e10.5 pancreatic epithelium (Fig. 4c). This tissue did not
express Pdx1, glucagon, or insulin, suggesting that it may
represent undifferentiated endoderm that was blocked prior to
pancreas specification. These results indicate that Gata6 may
lie upstream of the earliest essential pancreatic transcription
factors Pdx1 and Ptf1a. Deletion of either Pdx1 or Ptf1a in
mice severely disrupts pancreas development and differentia-
tion, but early pancreatic rudiments are able to form (Krapp et
al., 1998; Offield et al., 1996).
The second class of Gata6 transgenics has a less severe
phenotype. A particularly striking feature of these embryos is
the presence of significantly enlarged ducts. This phenotype
may result from a failure of the ductal epithelium to
differentiate, causing an accumulation of precursor cells.
Consistent with this possibility, we observe a modest increase
in the number of Ngn3-expressing cells and a higher proportion
of ductal cells expressing Nkx6.1 and Pdx1. It also appears that
the Gata6 transgene is interfering with normal cell type
maturation; many of the differentiated islet cells that form are
aberrantly localized within the duct cells or are located
immediately adjacent to the ductal epithelium. Only a small
percentage of differentiated cell types remain, which may be
evidence of a migration defect due to the absence of the correct
local environmental signals. Finally, the enlarged duct struc-
tures do not exhibit normal branching. Gata6 has been shown to
be an important regulator of branching and morphogenesis in
the lung (Koutsourakis et al., 2001; Liu et al., 2002b) and
therefore may play a similar role in the developing pancreas.
Gata6 and Nkx2.2 may co-regulate islet-specific transcription
factors
Although disruption of Gata6 function blocks the earliest
stages of pancreas development, it remains possible that Gata6
also functions at later stages in the islet where it is expressed at
high levels in a subset of endocrine cells. In support of this, we
determined that Gata6 interacts with the essential islet
transcription factor, Nkx2.2. It is believed that specific functions
of Gata4, Gata5, and Gata6 in cardiogenesis are determined by
specific protein–protein interactions. Interestingly, Nkx2.5 can
interact with Gata4 and Gata5 in the heart, but does not interact
with Gata6 (Durocher et al., 1997). This indicates that not all
Gata factors are able to interact with every Nkx2 family member,
and the specific interactions that can form may be critical in the
regulation of cell-type specific targets. Additionally, Gata6
appears to have more extensive functions in the pancreas than
Nkx2.2, since the Gata6 transgenic phenotype is more severe
than the phenotype caused by a deletion of Nkx2.2. Identifica-
tion of Nkx2.2 and Gata6 co-regulated genes in the islet is a
current focus of our research.Acknowledgments
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